Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02707692 · ClinicalTrials.gov registry record · NA
Perturbing of HIV Reservoir With Immune Stimulation
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT02707692 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 54 participants.
The verdict
NCT02707692, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the impact of Pneumococcus and Influenza vaccines on the HIV transcriptional activity in individuals who are virologically suppressed for at least 48 weeks on similar ART. The proposed study is a randomized double-blinded control trial conducted over 28 weeks. Randomized interventions will be injections of Influenza vaccine, Pneumococcal vaccine, and Placebo. Each participant will receive each injection but in a randomized order.
Interventions
- OTHER Placebo
- BIOLOGICAL Fluarix
- BIOLOGICAL Pneumovax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2016-08 |
| Est. Completion | 2022-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02707692
The ClinicalTrials.gov registry entry for NCT02707692 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02707692 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02707692 about?
NCT02707692 is a clinical study titled "Perturbing of HIV Reservoir With Immune Stimulation". The purpose of this study is to determine the impact of Pneumococcus and Influenza vaccines on the HIV transcriptional activity in individuals who are virologically suppressed for at least 48 weeks on similar ART. The proposed study is a randomized double-blinded control trial conducted over 28 week...
What is the current status of trial NCT02707692?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2016-08. Estimated completion is 2022-01.
What interventions are being tested in trial NCT02707692?
The interventions under investigation include: Placebo (OTHER), Fluarix (BIOLOGICAL), Pneumovax (BIOLOGICAL).
Who is sponsoring clinical trial NCT02707692?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.